Kazia Therapeutics Ltd ADR Earnings

The next earnings date for Kazia Therapeutics Ltd ADR has not yet been scheduled.

Analyst Estimates of Kazia Therapeutics Ltd ADR Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Kazia Therapeutics Ltd ADR Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
06/30/2021	---	$-0.01	---
03/31/2021	---	$-0.01	---
12/31/2020	---	$-0.02	---
09/30/2020	---	$-0.02	---
06/30/2020	---	$-0.03	---
03/31/2020	---	$-0.03	---
12/31/2019	---	$-0.03	---
09/30/2019	---	$-0.03	---
06/30/2019	---	$-0.02	---
03/31/2019	---	$-0.02	---
12/31/2018	---	$-0.04	---
09/30/2018	---	$-0.04	---
06/30/2018	---	$-0.05	---
02/21/2018	---	$0.01	---
12/31/2017	---	$0.00	---
08/30/2017	After Market	$-0.13	---
06/30/2017	---	$-0.05	---
02/22/2017	Before Market	$-0.09	---
10/19/2016	---	$-0.19	---
08/30/2016	Before Market	$-0.04	---
06/30/2016	---	$-0.07	---
02/22/2016	Before Market	$-0.09	---
12/31/2015	---	$-0.03	---
08/31/2015	After Market	$-0.03	---
06/30/2015	---	$-0.06	---
02/28/2015	After Market	$-0.06	---
10/03/2014	After Market	$-0.05	---
09/30/2014	---	$-0.06	---
06/30/2014	---	$-0.12	---
02/28/2014	Before Market	$-0.12	---
12/31/2013	---	$-0.09	---
09/30/2013	---	$-0.10	---
12/31/2012	---	$-0.01	---
09/30/2012	---	$-0.01	---
06/30/2012	---	$0.04	---
03/31/2012	---	$0.04	---
12/31/2011	---	$0.02	---
09/30/2011	---	$0.02	---
06/30/2011	---	$-0.08	---
03/31/2011	---	$-0.08	---
12/31/2010	---	$-0.32	---

More About Kazia Therapeutics Ltd ADR

Website

https://www.kaziatherapeutics.com

Country

USA

Full Time Employees

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3 that is in Phase I clinical trial to treat advanced solid tumors and ovarian cancer. The company has collaborations with the Australian and New Zealand Children's Haematology/Oncology Group, Genentech Inc., Global Coalition for Adaptive Research, Vivesto AB, Simcere Pharmaceutical Group Ltd, Evotec SE, Sovargen Co., Ltd, and QIMR Berghofer Medical Research Institute. Kazia Therapeutics Limited was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.

“Kazia Therapeutics Ltd ADR Earnings” Can Refer to the Kazia Therapeutics Ltd ADR Earnings Date

Some people say “Kazia Therapeutics Ltd ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Kazia Therapeutics Ltd ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Kazia Therapeutics Ltd ADR Stock on the Earnings Date

If you own Kazia Therapeutics Ltd ADR stock (KZIA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Kazia Therapeutics Ltd ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Kazia Therapeutics Ltd ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Kazia Therapeutics Ltd ADR Earnings

You can contact us any time if you would like to ask questions about Kazia Therapeutics Ltd ADR earnings or anything else related to the stock market.